CLINICAL_TRIALS trial_result · 2022-06-03

Clinical Trial Update: Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia [Phase 2]

Phase 2 trial evaluating the efficacy and safety of Roxadustat for chemotherapy-induced anemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Kyntra Bio | Conditions: Chemotherapy Induced Anemia | Phase 2 | Status: COMPLETED | Results posted: 2022-06-03